C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.665 AUD
-0.3%
Market Closed
Updated:
May 16, 2024
Cyclopharm Ltd
Operating Expenses
|
Cyclopharm Ltd
Operating Expenses Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Operating Expenses
-AU$26.1m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-11%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Operating Expenses
-AU$6.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Operating Expenses
-AU$29.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-13%
|
|
|
Cochlear Ltd
ASX:COH
|
Operating Expenses
-AU$1.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-11%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Operating Expenses
-AU$8.2m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-16%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Operating Expenses
-AU$10.9m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Operating Expenses?
Operating Expenses
-26.1m
AUD
-26.1m
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Operating Expenses amounts to -26.1m AUD.
What is Cyclopharm Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-11%
-11%
Over the last year, the Operating Expenses growth was -12%. The average annual Operating Expenses growth rates for Cyclopharm Ltd have been -17% over the past three years , -20% over the past five years , and -11% over the past ten years .
You don't have any saved screeners yet
